Back to top

Image: Bigstock

BioCryst Pharmaceuticals (BCRX) in Focus: Stock Moves 8.5% Higher

Read MoreHide Full Article

BioCryst Pharmaceuticals, Inc. BCRX was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.2700 –$3.1500 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

BioCryst Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%. 

BioCryst Pharmaceuticals, Inc. Price

Investors interested in the Medical - Drugs industry may consider Galmed Pharmaceuticals Ltd. GLMD, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BCRX going up? Or down? Predict to see what others think:Up or Down

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>